These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38246505)
1. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study. Li Z; Yang K Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505 [No Abstract] [Full Text] [Related]
2. Comment Regarding "Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus". Zhang H Gastroenterology; 2024 May; 166(5):943. PubMed ID: 37741421 [No Abstract] [Full Text] [Related]
3. The Effect of Proton Pump Inhibitors on Barrett's Esophagus. Dunbar KB; Souza RF; Spechler SJ Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202 [TBL] [Abstract][Full Text] [Related]
4. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
5. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477 [TBL] [Abstract][Full Text] [Related]
6. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698 [TBL] [Abstract][Full Text] [Related]
7. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193 [TBL] [Abstract][Full Text] [Related]
8. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma. Abrams JA; Chak A J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700 [No Abstract] [Full Text] [Related]
9. The Role of Acid Suppression in Barrett's Esophagus. Elias PS; Castell DO Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599 [TBL] [Abstract][Full Text] [Related]
10. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)? Spechler SJ Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402 [TBL] [Abstract][Full Text] [Related]
11. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population. Morganstern B; Anandasabapathy S Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085 [TBL] [Abstract][Full Text] [Related]
12. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Thrift AP Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368 [TBL] [Abstract][Full Text] [Related]
13. Acid suppression and surgical therapy for Barrett's oesophagus. de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus]. Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403 [TBL] [Abstract][Full Text] [Related]
15. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
16. Unraveling the impact of irritability on esophageal diseases: Insights from multivariable Mendelian randomization analysis. Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Shang Q; Zhang H; Zeng X; Yuan Y J Affect Disord; 2024 Dec; 366():189-195. PubMed ID: 39187201 [TBL] [Abstract][Full Text] [Related]
17. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029 [TBL] [Abstract][Full Text] [Related]
19. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
20. Medical treatment of Barrett's esophagus: can it prevent cancer? Sampliner RE Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]